Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for Covid-19 treatment

The mortality rate of critically ill patients with acute respiratory distress syndrome (ARDS) is 30.9% to 46.1%. The emergence of the coronavirus disease 2019 (Covid-19) has become a global issue with raising dire concerns. Patients with severe Covid-19 may progress toward ARDS. Mesenchymal stem cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wendi, Lei, Wei, Jiang, Lina, Gao, Siqi, Hu, Shijun, Zhao, Zi-Gang, Niu, Chun-Yu, Zhao, Zhen-Ao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107778/
https://www.ncbi.nlm.nih.gov/pubmed/33971907
http://dx.doi.org/10.1186/s12967-021-02862-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107778/
https://www.ncbi.nlm.nih.gov/pubmed/33971907
http://dx.doi.org/10.1186/s12967-021-02862-x

Ejemplares similares